phentermine has been researched along with Serotonin Syndrome in 1 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rader, WA | 1 |
| Steelman, GM | 1 |
| Westman, EC | 1 |
1 other study available for phentermine and Serotonin Syndrome
| Article | Year |
|---|---|
Clinical experience using appetite suppressants and SSRIs.
Topics: Appetite Depressants; Bariatric Medicine; Drug Therapy, Combination; Humans; Obesity; Phentermine; P | 2008 |